Kevin DeJong, an associate in Goodwin’s Litigation Group, focuses his practice on intellectual property litigation. Mr. DeJong has advised clients in a variety of intellectual property-related litigations in the pharmaceutical, medical device and software industries.

Experience

ERFAHRUNG

工作经历

Mr. DeJong's representative matters include:

  • Teva Pharmaceuticals USA et al. v. Sandoz, Inc. et al. and Mylan Pharmaceuticals Inc. et al. (S.D.N.Y.). Represented patent owner in Hatch-Waxman dispute regarding generic version of Copaxone, a complex mixture of polypeptides. Was part of trial team that obtained decision in favor of Teva finding all claims infringed, valid, and enforceable.
  • Teva Pharmaceuticals USA et al. v. Sandoz, Inc. et al. and Mylan Pharmaceuticals Inc. et al. (S.D.N.Y.). Represented patent owner in patent litigation involving techniques to measure the molecular weight of complex mixtures of polypeptides.
  • Momenta Pharmaceuticals v. Teva Pharmaceuticals (D. Mass). Represented Teva in patent litigation related to methods of evaluating low molecular weight heparins.
  • iHance, Inc. v. Eloqua Ltd. (E.D. Va.). Represented Eloqua in patent litigation involving technology for monitoring email and website behavior of email recipients.
  • Abbott Point of Care, Inc. v. Epocal, Inc. (N.D. Ala.). Represented Epocal in patent litigation dispute related to point-of-care blood testing diagnostic devices. Was part of trial team that obtained jury verdict in Epocal’s favor in finding no infringement.
  • X-ray Optical Systems v. Innov-X (N.D.N.Y.). Represented Innov-X in patent ownership dispute relating to x-ray optics technology.
  • Asentinel LLC v. The Info Group, Inc. et al. (W.D. Tenn.). Represented Veramark in patent litigation involving technology used in analyzing telecommunications invoices.
Professional Activities

Mr. DeJong is a member of the Boston Intellectual Property Inn of Court, the Boston Bar Association and the New Hampshire Bar Association. Mr. DeJong also serves as an editor of the firm’s biosimilars blog, www.bigmoleculewatch.com.

Professional Experience

Prior to joining Goodwin, Mr. DeJong worked as an engineer in the pharmaceutical and biotechnology industry. He has extensive experience in pharmaceutical and biotech manufacturing, process development and scale-up, and equipment design.

Recognition

While attending law school, Mr. DeJong served as Editor-in-Chief of the 49th Volume of IDEA: The Intellectual Property Law Review.

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2009
University of New Hampshire School of Law

(magna cum laude)

B.S., Chemical Engineering, 1999
Northwestern University

Admissions

Bar

U.S. Patent and Trademark Office (USPTO)
Massachusetts
New Hampshire

Courts

U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the District of Massachusetts
U.S. District Court of New Hampshire
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师